13F HOLDINGS REPORT
Opaleye Management Inc.
Quarter ended Q2 2023 · Filed May 15, 2023 · Accession 0001493152-23-016769
Total Value
$333.9M
Positions
41
Other Managers
0
Confidential Omitted
No
Holdings (41)
| # | Issuer | Ticker / CUSIP | Shares | Value | % of Filing |
|---|---|---|---|---|---|
| 1 | HARROW HEALTH INC | HROW | 3,775,000 | $79.9M | 23.92% |
| 2 | OCULAR THERAPEUTIX INC | OCUL | 6,105,900 | $32.2M | 9.64% |
| 3 | TELA BIO INC | TELA | 2,072,813 | $22.1M | 6.61% |
| 4 | RHYTHM PHARMACEUTICALS INC | RYTM | 735,000 | $13.1M | 3.93% |
| 5 | CRINETICS PHARMACEUTICALS INC | CRNX | 785,794 | $12.6M | 3.78% |
| 6 | KARYOPHARM THERAPEUTICS INC | KPTI | 2,810,800 | $10.9M | 3.27% |
| 7 | KEROS THERAPEUTICS INC | KROS | 238,000 | $10.2M | 3.04% |
| 8 | TRACON PHARMACEUTICALS INC | 89237H209 | 4,764,508 | $9.0M | 2.70% |
| 9 | ETON PHARMACEUTICALS INC | ETON | 2,185,000 | $8.4M | 2.52% |
| 10 | PROTARA THERAPEUTICS INC | TARA | 2,692,594 | $8.1M | 2.42% |
| 11 | BIOHAVEN LTD | BHVN | 540,000 | $7.4M | 2.21% |
| 12 | CYTOKINETICS INC | CYTK | 207,500 | $7.3M | 2.19% |
| 13 | KALVISTA PHARMACEUTICALS INC | KALV | 923,200 | $7.3M | 2.17% |
| 14 | VAXCYTE INC | PCVX | 177,000 | $6.6M | 1.99% |
| 15 | LARIMAR THERAPEUTICS INC | LRMR | 1,401,000 | $6.3M | 1.90% |
| 16 | THERAVANCE BIOPHARMA INC | TBPH | 546,304 | $5.9M | 1.78% |
| 17 | ARCUTIS BIOTHERAPEUTICS INC | ARQT | 502,000 | $5.5M | 1.65% |
| 18 | 4D MOLECULAR THERAPEUTICS INC | FDMT | 314,000 | $5.4M | 1.62% |
| 19 | JOUNCE THERAPEUTICS INC | 481116101 | 2,880,000 | $5.3M | 1.60% |
| 20 | MARINUS PHARMACEUTICALS INC | 56854Q200 | 765,000 | $5.3M | 1.58% |
| 21 | XOMA CORP DEL | XOMAP | 243,000 | $5.1M | 1.54% |
| 22 | EDGEWISE THERAPEUTICS INC | EWTX | 750,000 | $5.0M | 1.50% |
| 23 | MORPHOSYS AG | 617760202 | 1,194,000 | $4.7M | 1.42% |
| 24 | IDEAYA BIOSCIENCES INC | IDYA | 343,000 | $4.7M | 1.41% |
| 25 | UROGEN PHARMA LTD | URGN | 505,000 | $4.7M | 1.40% |
| 26 | THESEUS PHARMACEUTICALS INC | 88369M101 | 488,100 | $4.3M | 1.30% |
| 27 | EDAP TMS S A | EDAP | 382,400 | $4.2M | 1.27% |
| 28 | ASTRIA THERAPEUTICS INC | 04635X102 | 302,000 | $4.1M | 1.23% |
| 29 | LIQUIDIA CORPORATION | LQDA | 575,200 | $4.0M | 1.19% |
| 30 | FORTRESS BIOTECH INC | FBIOP | 4,573,600 | $3.8M | 1.12% |
| 31 | PHATHOM PHARMACEUTICALS INC | PHAT | 496,000 | $3.5M | 1.06% |
| 32 | CODEXIS INC | CDXS | 750,000 | $3.1M | 0.93% |
| 33 | IOVANCE BIOTHERAPEUTICS INC | IOVA | 421,000 | $2.6M | 0.77% |
| 34 | RELAY THERAPEUTICS INC | RLAY | 125,500 | $2.1M | 0.62% |
| 35 | KEZAR LIFE SCIENCES INC | KZR | 625,000 | $2.0M | 0.59% |
| 36 | MINERALYS THERAPEUTICS INC | MLYS | 115,000 | $1.8M | 0.54% |
| 37 | STEREOTAXIS INC | STXS | 867,100 | $1.8M | 0.53% |
| 38 | TREVI THERAPEUTICS INC | TRVI | 835,800 | $1.5M | 0.46% |
| 39 | PROQR THERAPEUTICS NV | N71542109 | 653,000 | $1.4M | 0.42% |
| 40 | NYXOAH S A | NYXH | 57,585 | $430,159 | 0.13% |
| 41 | MODULAR MEDICAL INC | MODD | 183,500 | $266,075 | 0.08% |